PROSPECTUS SUPPLEMENT NO. 14 Filed Pursuant to Rule 424(b)(3) (to prospectus dated July 12, 2021) Registration No...
PROSPECTUS SUPPLEMENT NO. 10 Filed Pursuant to Rule 424(b)(3) (to prospectus dated September 15, 2021) Registration No...
PROSPECTUS SUPPLEMENT NO. 1 Filed Pursuant to Rule 424(b)(3) (to prospectus dated April 20, 2022) Registration No...
63667468356582160001719406--12-312022Q1false00NRX Pharmaceuticals, Inc.66641314585105500.200.7110001719406us-gaap:OptionMembernrxp:MergerAgreementW...
TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No...
BRP Group, Inc. (“BRP Group” or the “Company”) (NASDAQ: BRP), an independent insurance distribution firm delivering tailored insurance solutions...
0001719406 false --12-31 2021 FY 0001719406 2021-01-01 2021-12-31...
TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:April 19, 2022...
BRP Group, Inc. (“BRP Group”) (NASDAQ: BRP) is pleased to welcome Richard Tallo as Chief Marketing Officer, effective April 11, 2022. In this...
As filed with the Securities and Exchange Commission on April 8, 2022 Registration No. 333-259336 UNI...
4691770134270955000001719406100000010000001050695105069531684831684858510550429734621.981.517.441.510P0Y0P0YP0Y0...
46917701342709550001719406--12-312021FYfalse100000010000001050695105069531684831684800NRX Pharmaceuticals...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.